X @Bloomberg
Bloomberg·2025-12-06 10:52
Indian pharmaceuticals firm Biocon will buy out minority shareholders in Biocon Biologics via a mix of cash and shares in a deal that values the biosimilars unit at $5.5 billion https://t.co/cVQbDOBkp4 ...
Indian pharmaceuticals firm Biocon will buy out minority shareholders in Biocon Biologics via a mix of cash and shares in a deal that values the biosimilars unit at $5.5 billion https://t.co/cVQbDOBkp4 ...